Friday, May 9, 2025
5/9/2025
Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization - PROJECT SUMMARY / ABSTRACT An effective HIV-1 vaccine will be one that elicits diverse anti-viral immune responses, including broadly neutralizing antibodies (bnAbs). Here, we focus on eliciting anti-CD4-binding site (CD4-BS) bnAbs, including VRC01-class bnAbs, through a guided immunization approach with specifically designed Env-derived immunogens. We previously reported on the design of a clade C Env-derived immunogen that activates naïve B cells expressing the bnAb precursors of VRC01-class antibodies in vivo. We also reported on the design of a second immunogen, derived from a clade B Env, that when administered as a 1st boost, increases the maturation of the emerging VRC01 B cells. Our proposal is based on our recent identification of two additional Env immunogens that complete the maturation of VRC01-class antibody responses towards their cross- neutralizing forms. Thus, after 4 Env immunizations of knock-in mice expressing elements of human VRC01 BCRs, we isolate VRC01-class antibodies that neutralize ~33% of heterologous tier 2 viruses. Here, our efforts focus on optimizing this immunization schema to improve the neutralizing breadth of the elicited VRC01-class antibodies. An important aspect of our proposal is that we will not limit our work to well-controlled knock-in mice, but transgenic mice that express diverse human VH/VL genes, as well. Because the B cell repertoire of these mice better reflects that of humans, we expect that our optimized immunization schema will not only lead to the generation of VRC01-class antibodies, as it does in the knock-in mice, but that additional classes of anti- CD4-BS antibody responses will also be elicited. A second important aspect of our proposal is that we will examine whether mRNA-based immunogen-delivery platforms accelerate the development of cross- neutralizing CD4-BS antibody responses.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).